A two-month-old male infant with tetralogy of Fallot underwent a right-sided modified Blalock-Taussig shunt using a 4 mm expanded polytetrafluoroethylene graft through a right thoracotomy. Five months later, the patient developed otitis media, followed by repeated relapses of pneumonia and fever of unknown origin. Multidetector-row computed tomography and angiography, performed at 12 months of age, revealed a pseudoaneurysm of the subclavian artery at the insertion of the modified Blalock-Taussig shunt. After 20 days of antibiotic therapy, the pseudoaneurysm and infected graft were successfully resected through a median sternotomy approach. This report describes the treatment strategy of this rare but potentially fatal complication after a modified Blalock-Taussig shunt operation.

Download full-text PDF

Source
http://dx.doi.org/10.1510/icvts.2008.184333DOI Listing

Publication Analysis

Top Keywords

modified blalock-taussig
16
blalock-taussig shunt
16
infected pseudoaneurysm
4
modified
4
pseudoaneurysm modified
4
blalock-taussig
4
shunt
4
shunt two-month-old
4
two-month-old male
4
male infant
4

Similar Publications

Background: In patients with adult congenital heart disease (ACHD), significant atrioventricular valve regurgitation is an important risk factor for poor outcomes, such as heart failure. However, in many cases, transcatheter intervention may reduce the risk profile to avoid a high surgical risk.

Case Summary: A 44-year-old man with complex ACHD in the form of a double-inlet left ventricle, congenitally corrected transposition of the great arteries, pulmonary atresia, atrial septal defect, and patent ductus arteriosus was referred for the treatment of severe tricuspid regurgitation.

View Article and Find Full Text PDF

This article provides a historical review and a current perspective on the procedures used to palliate cyanosis in ductal-dependent infants. Eighty years ago, Helen Taussig, Alfred Blalock, and Vivien Thomas developed the first effective treatment. The Blalock-Taussig-Thomas (BTT) shunt is the historical predecessor of both the contemporary-modified BTT shunt and interventional stenting of the Patent Ductus Arteriosus (PDA).

View Article and Find Full Text PDF

Background: While several studies have explored the outcomes of transcatheter interventions for modified Blalock-Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).

Methods: This retrospective study was conducted between 2020 and 2024, when 24 urgent interventions were performed on 17 patients at our center. We recorded several key outcomes, including early and late intervention-related complications, the need for reintervention, the interval between the NP and the first intervention, shunt patency following the intervention, associated morbidities, and thrombosis-related sudden events.

View Article and Find Full Text PDF

This article provides a historical review and a current perspective on the procedures used to palliate cyanosis in ductal-dependent infants. Eighty years ago, Helen Taussig, Alfred Blalock and Vivien Thomas developed the first effective treatment. The Blalock-Taussig-Thomas (BTT) shunt is the historical predecessor of both the contemporary modified BTT shunt and interventional stenting of the Patent Ductus Arteriosus (PDA).

View Article and Find Full Text PDF

Clinical outcomes of right ventricular outflow tract stenting compared to surgical shunting in late-presenting children.

Front Cardiovasc Med

October 2024

Division of Non-Invasive Diagnostic and Cardiovacular Imaging, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, Indonesia.

Article Synopsis
  • The study examined the use of right ventricular outflow tract (RVOT) stenting versus the modified Blalock-Taussig shunt (mBTS) as treatments for children with stenotic RVOTs aged 1 to 18, revealing limited literature on their comparative effectiveness.* -
  • Data from 58 patients indicated that both procedures resulted in similar rates of major adverse cardiovascular events (MACE), but mBTS patients had shorter overall hospital stays, while RVOT stenting led to shorter ICU stays.* -
  • Overall, RVOT stenting showed comparable results to mBTS concerning MACE and oxygen saturation levels at discharge, suggesting it could be a viable option for palliation in this patient population.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!